Frontiers in Drug Safety and Regulation is a peer-reviewed english-language open-access journal published by Frontiers Media S.A. in Switzerland, operating under an open-access model since 2021. The journal covers Therapeutics. Pharmacology.
Authors are required to pay an article processing charge to publish in Frontiers in Drug Safety and Regulation; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
Keywords
medicine, pharmacogenomics, clinical pharmacology and therapeutics
At a glance
- Publisher
- Frontiers Media S.A.
- Country
- Switzerland
- Primary language
- English
- License
- CC BY
- Peer review
- Anonymous peer review
- OA since
- 2021
ISSN
- electronic
- 2674-0869
Frequently asked questions
Is Frontiers in Drug Safety and Regulation peer-reviewed?
Yes — Frontiers in Drug Safety and Regulation operates a Anonymous peer review review process.
Does Frontiers in Drug Safety and Regulation charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Frontiers in Drug Safety and Regulation publish?
Frontiers in Drug Safety and Regulation publishes research in Therapeutics. Pharmacology.
What languages does Frontiers in Drug Safety and Regulation accept?
Frontiers in Drug Safety and Regulation accepts manuscripts in English.
What is the ISSN of Frontiers in Drug Safety and Regulation?
ISSN:
2674-0869 (electronic).How do I submit a manuscript to Frontiers in Drug Safety and Regulation?
Submit through the journal's official portal: visit submission page →